+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06101290

Study of Ablative Local Therapy with Systemic Treatment for Oligo-Progressive Genitourinary Tumors including Prostate, Urothelial, and Renal Cell Cancer

Led by University of California, Davis · Updated on 2026-06-30

150

Participants Needed

1

Research Sites

265 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the clinical benefits of adding locally ablative therapies to ongoing systemic treatment for people with oligo-progressive solid genitourinary tumors, including prostate cancer, urothelial carcinoma, and renal cell carcinoma. This phase 2 pragmatic study aims to understand if continuing systemic therapy along with targeted local treatments can control the disease and delay the need to change or stop systemic therapy. The primary focus is on time to treatment failure and disease control at three months after local therapy. Participants receive ablative local therapy, which includes stereotactic ablative radiotherapy SABR or interventional radiology IR ablation, selected based on the treating physicians discretion. These treatments are added to their ongoing systemic cancer therapy. The study follows participants for up to five years after the local therapy to monitor outcomes and treatment effects. The study is conducted at a single site and does not include randomization or masking. During the study, participants continue their systemic therapy with no more than a 30-day break for local treatment. Researchers assess disease control at three months after starting local therapy and monitor adverse events related to the ablative therapies for up to two years. They also track overall survival and time to treatment failure for up to one year. Participants will undergo regular evaluations to measure these outcomes and ensure safety throughout the study period, which may last several years.

CONDITIONS

Brief Title

Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)

Research Team

O

Office of Clinical Research

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here